Ruth Smit
Papers
2
Total Citations
41
H-Index
2
About
Ruth Smit is a leading researcher in prostate cancer imaging and focal therapy, whose work bridges radiology and urologic oncology. Her primary research areas include multiparametric MRI (mpMRI), PSMA-PET/MRI, and minimally invasive ablative treatments for localized prostate cancer. Smit’s major contributions center on improving diagnostic accuracy and treatment monitoring. In her landmark ProStaPET study (2021, 27 citations), she prospectively compared [18F]DCFPyL PET/MRI to standard mpMRI for detecting clinically significant prostate cancer, using radical prostatectomy histopathology as the gold standard—demonstrating the added value of hybrid imaging in tumor localization. She also pioneered work on transperineal focal laser ablation (TPLA), showing in a 2023 study (14 citations) that MRI and contrast-enhanced ultrasound can reliably visualize the three-dimensional treatment effect, addressing the critical need for dosimetry models in focal therapy. Her research directly impacts clinical decision-making by enabling more precise cancer detection and less invasive treatment monitoring. Smit’s work is highly regarded for its methodological rigor and translational potential, making her a key voice in the evolution of prostate cancer management toward personalized, image-guided approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2